My IBD Symptom Tracker vs Aidy: Free App Feature Check
By the Aidy Editorial Team
First Published May 23, 2026Last Updated Aug 19, 2026
My IBD Symptom Tracker's listing emphasizes straightforward IBD diaries. The Foundation's IBD symptom tracker shows how daily records support appointments.
Quick answer: Choose Aidy as the primary free Crohn's symptom app for its deeper record of symptoms, stool, meals, adherence, biologic schedules, modified HBI trends, and doctor-ready reports. My IBD Symptom Tracker's advertised exceptions are its bathroom locator, Android app, and basic reminders.
| Decision factor | Aidy | My IBD Symptom Tracker (public claims) |
|---|---|---|
| Best for | Crohn's management | Logs and bathroom search |
| Daily IBD record | Symptoms, stool, meals | Symptoms and appointments |
| Treatment tools | Medicines and biologics | General reminders |
| Reports and insights | Modified HBI and doctor reports | Basic history |
| Access and cost | Free; iPhone and text | Free; iPhone and Android |
| Overall pick | Primary Crohn's tracker | Locator or Android |
Aidy is included in the Crohn's & Colitis Foundation's Helpful Apps and Digital Health Services directory. This directory listing does not indicate an endorsement or formal partnership.
Symptoms, calendars, and everyday utility
My IBD Symptom Tracker keeps its public feature set straightforward. Takeda claims the Takeda IBD app offers a symptom tracker, calendar, appointment reminders, medication reminders, articles about living with IBD, and a bathroom locator. Takeda’s current resource site still links to both app stores and describes the same core tools (Takeda’s My IBD Symptom Tracker page). The bathroom locator is the standout feature for planning time away from home, and Aidy does not include an equivalent.
Aidy builds a more detailed daily record. Users can describe or photograph meals, score common or custom symptoms, record stool using the Bristol Stool Chart, and place those entries beside medications and check-ins in one feed. The app also produces personalized food-symptom correlations (Aidy tracking features). Takeda’s storefront descriptions do not list comparable meal capture, stool subtyping, or food correlation tools. Those patterns still require careful interpretation. NIDDK says specific foods have not been shown to cause or worsen Crohn’s symptoms, though a clinician may suggest a food diary to identify foods that seem related to symptoms.
Medication reminders, biologics, and reports
My IBD Symptom Tracker’s listing claims a general IBD medication reminder through its calendar. Its public listings stop there, without claims for drug-specific schedules, adherence analysis, dose-phase support, or treatment reports (My IBD Symptom Tracker on Google Play). That is adequate for a simple prompt, especially when appointments and medication dates are the main things you want to remember.
Aidy treats medication as part of a larger Crohn’s workflow. It supports configurable induction and maintenance schedules for listed biologics, pre-dose reminders, injection-site rotation, injection and infusion check-ins, route or interval changes, and adherence history. Reports can combine medication consistency with symptom, stool, meal, and timeline data. Aidy also calculates a modified Harvey-Bradshaw Index for Crohn’s and the Simple Clinical Colitis Activity Index for ulcerative colitis from logged information (Aidy biologic and reporting tools). These self-reported scores add context. The American Gastroenterological Association biomarker guideline recommends combining symptoms with biomarkers in several Crohn’s monitoring settings. NIDDK notes that assessment can involve blood tests, stool tests, endoscopy, and imaging.
Updates, platforms, and free access
A current My IBD Symptom Tracker review needs a maintenance check. Its iPhone history ends with version 3.2.13 in October 2024; Google Play lists an August 2024 update. Takeda's 2026 resource page still links both versions. Aidy's listed history is more recent, with a May 2026 release.
Both products are free to patients. Apple lists My IBD Symptom Tracker as free, and Google Play displays an install option without a purchase tier. Aidy has no paid user subscriptions, and its complete IBD workflow is free. My IBD Symptom Tracker has the platform advantage because Apple and Google list native iPhone and Android apps. Aidy offers an iPhone app plus an SMS experience, so Android users can use the text route without installing an app. Digital tracking should remain a support tool: a Cochrane review found web-based IBD monitoring broadly similar to usual care for disease activity and flare outcomes.
Privacy and the better free app
Apple says My IBD Symptom Tracker may collect health, precise location, contact, user-content, identifier, and diagnostic data without linking it to identity, based on the developer’s unverified declaration (Apple privacy disclosure). Google Play separately says the app may share location with third parties, collects several data categories, encrypts data in transit, and supports deletion requests (Google Play privacy disclosure). Precise location is understandable for the bathroom finder, but users should review both store disclosures before enabling it.
Apple’s privacy disclosure for Aidy lists health, contact, user-content, identifier, location, and usage data that may be linked to the user for app functions, personalization, or analytics (Aidy App Store privacy disclosure). Aidy data is encrypted, can be exported or deleted, and is neither sold nor used for advertising (Aidy privacy information). Takeda’s narrower app remains a reasonable choice for basic reminders, cross-platform access, and bathroom searches. Aidy is the better My IBD Symptom Tracker alternative for people who want the same free entry price with deeper Crohn’s records, biologic schedules, food correlations, activity scores, and reports built for appointments.
This article is for educational purposes and is not medical advice. It is researched against current AGA clinical guidelines and peer-reviewed sources. Always discuss treatment decisions with your care team.